BEREBORN BIOTECHNOLOGY LIMITED – Trademark Portfolio
Entity Type: 03
BEREBORN BIOTECHNOLOGY LIMITED holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 2 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include CELINFINITE. The owner is based in Arcadia, CA.
Arcadia, CA 91006
Showing of trademarks Trademarks
Trademark Classifications
BEREBORN BIOTECHNOLOGY LIMITED's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does BEREBORN BIOTECHNOLOGY LIMITED have?
BEREBORN BIOTECHNOLOGY LIMITED has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does BEREBORN BIOTECHNOLOGY LIMITED file in?
BEREBORN BIOTECHNOLOGY LIMITED files trademarks across 3 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals). Class 35 covers advertising; business management; business administration; office functions.
What are BEREBORN BIOTECHNOLOGY LIMITED's most well-known trademarks?
BEREBORN BIOTECHNOLOGY LIMITED's registered trademark portfolio includes well-known marks such as CELINFINITE. These are among 2 currently registered trademarks in the portfolio.
What is BEREBORN BIOTECHNOLOGY LIMITED's trademark registration success rate?
BEREBORN BIOTECHNOLOGY LIMITED has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.